CXCL10 levels identify individuals with rapid fibrosis at 12 months post-transplant for hepatitis C virus and predict treatment response. [electronic resource]
Producer: 20141218Description: 569-78 p. digitalISSN:- 1399-0012
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Allografts
- Antiviral Agents -- therapeutic use
- Biomarkers -- blood
- Chemokine CXCL10 -- blood
- Disease Progression
- Female
- Follow-Up Studies
- Graft Survival
- Hepacivirus -- isolation & purification
- Hepatitis C -- blood
- Humans
- Liver Cirrhosis -- diagnosis
- Liver Transplantation -- adverse effects
- Male
- Middle Aged
- Postoperative Complications -- diagnosis
- Prognosis
- ROC Curve
- Recurrence
- Risk Factors
- Survival Rate
- Young Adult
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.